𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tuberculosis drugs: new candidates and how to find more

✍ Scribed by Sala, Claudia; Hartkoorn, Ruben C

Book ID
111694223
Publisher
Future Medicine
Year
2011
Tongue
English
Weight
673 KB
Volume
6
Category
Article
ISSN
1746-0913

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

New Strategies Combating Bacterial Infec
New Strategies Combating Bacterial Infection || Promising Current Drug Candidates in Clinical Trials and Natural Products Against Multidrug-Resistant Tuberculosis
✍ Ahmad, Iqbal; Aqil, Farrukh πŸ“‚ Article πŸ“… 2008 πŸ› Wiley-VCH Verlag GmbH & Co. KGaA 🌐 German βš– 305 KB πŸ‘ 1 views

Combating bacterial infections calls for a multidisciplinary approach and this is what is on offer here. Written by an experienced international team of researchers from various fields ranging from biotechnology to traditional medicine, the book provides complete and comprehensive coverage of topics

Chest computed tomography is more likely
Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates
✍ Jiwon Lyu; Sung-Gyu Lee; Shin Hwang; Sang-Oh Lee; Oh-Hyun Cho; Eun Jin Chae; San πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 128 KB

Although the detection and treatment of latent tuberculosis infections (LTBIs) in transplant candidates are essential, current diagnostic methods for LTBIs are limited, especially in immunocompromised subjects. Pretransplant chest computed tomography (CT) may reveal more LTBI foci and thus predict t

The interaction topology of Mycobacteriu
The interaction topology of Mycobacterium tuberculosis genes response to capreomycin and novel clues for more drug targets
✍ Fei Zheng; Jianping Xie πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 677 KB

The resurgence of tuberculosis (TB) and emergence of multidrug-resistant TB (MDR-TB) are significant obstacles to stop TB treatment. Capreomycin (CPM) is regarded as an ideal second-line treatment for TB as well as for MDR-TB. However, the inexorable emergence of capreomycin resistant TB cases accen